InsiderClue
Insiders · Profile

HEALY JAMES

Director at BioAge Labs · Director at Rapport Therapeutics · Director at ArriVent BioPharma · and 5 more. Filing since 28 Mar 2012. CIK 0001245624

BIOA BioAge Labs, Inc. Director · 1 trade RAPP Rapport Therapeutics, Inc. Director · 2 trades AVBP ArriVent BioPharma, Inc. Director · 1 trade NTRA Natera, Inc. Director · 7 trades CHRS Coherus Oncology, Inc. Director · 9 trades BOLT Bolt Biotherapeutics, Inc. Director · 1 trade PDSB PDS Biotechnology Corp Director · 2 trades AMRN AMARIN CORP PLC\UK Director · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
BIOA BioAge Labs, Inc.
27 Sep 2024
Director
Bought
666,665
$12.00M
42.7%
RAPP Rapport Therapeutics, Inc.
1 Jul 2024
Director
Bought
44,032
$1.08M
opened
RAPP Rapport Therapeutics, Inc.
10 Jun 2024
Director
Bought
558,824
$9.50M
42.8%
AVBP ArriVent BioPharma, Inc.
30 Jan 2024
Director
Bought
444,444
$8.00M
35.5%
NTRA Natera, Inc.
13 Dec 2023
Director
Sold at will
644,000
$37.84M
100%
NTRA Natera, Inc.
16 Nov 2022
Director
Sold, plan not stated
2,400
$90.50K
100%
CHRS Coherus Oncology, Inc.
29 Sep 2021
Director
Sold, plan not stated
286,076
$4.61M
100%
CHRS Coherus Oncology, Inc.
28 Sep 2021
Director
Sold, plan not stated
48,329
$829.81K
14.5%
CHRS Coherus Oncology, Inc.
27 Sep 2021
Director
Sold, plan not stated
100,150
$1.81M
23.0%
NTRA Natera, Inc.
22 Jul 2021
Director
Bought
2,400
$271.20K
opened
BOLT Bolt Biotherapeutics, Inc.
9 Feb 2021
Director
Bought
450,000
$9.00M
19.5%
CHRS Coherus Oncology, Inc.
2 Jul 2019
Director
Sold, plan not stated
160,000
$3.62M
7.6%
CHRS Coherus Oncology, Inc.
28 Jun 2019
Director
Sold, plan not stated
200,000
$4.41M
8.7%
CHRS Coherus Oncology, Inc.
20 Jun 2019
Director
Sold, plan not stated
317,130
$6.78M
12.1%
CHRS Coherus Oncology, Inc.
22 May 2019
Director
Sold, plan not stated
257,870
$5.34M
9.0%
CHRS Coherus Oncology, Inc.
29 Aug 2018
Director
Sold, plan not stated
25,000
$512.50K
0.9%
PDSB PDS Biotechnology Corp
11 Mar 2016
Director
Bought
541,343
$3.95M
23.4%
PDSB PDS Biotechnology Corp
6 Oct 2015
Director
Bought
450,000
$4.95M
24.9%
NTRA Natera, Inc.
8 Jul 2015
Director
Bought
175,000
$3.15M
87.5%
NTRA Natera, Inc.
8 Jul 2015
Director
Bought
175,000
$3.15M
87.5%
NTRA Natera, Inc.
2 Jul 2015
Director
Bought
200,000
$4.56M
opened
NTRA Natera, Inc.
2 Jul 2015
Director
Bought
200,000
$4.56M
opened
CHRS Coherus Oncology, Inc.
12 Nov 2014
Director
Bought
425,926
$5.75M
20.0%
AMRN AMARIN CORP PLC\UK
3 Apr 2012
Director
Sold, plan not stated
1,735,650
$19.06M
23.9%
AMRN AMARIN CORP PLC\UK
2 Apr 2012
Director
Sold, plan not stated
264,350
$2.91M
3.5%
AMRN AMARIN CORP PLC\UK
29 Mar 2012
Director
Sold, plan not stated
993,698
$10.91M
11.7%
AMRN AMARIN CORP PLC\UK
28 Mar 2012
Director
Sold, plan not stated
6,302
$73.92K
0.1%
27 decisions on file.